Technical Analysis for SNPHY - Santen Pharmaceutical Co

Grade Last Price % Change Price Change
F 13.65 -2.50% -0.3500
SNPHY closed down 2.5 percent on Friday, April 9, 2021, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical SNPHY trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish -2.50%
Pocket Pivot Bullish Swing Setup -2.50%
Fell Below 20 DMA Bearish 0.44%
Doji - Bullish? Reversal 0.44%
Down 3 Days in a Row Weakness 0.44%
20 DMA Support Bullish -0.66%
Older End-of-Day Signals for SNPHY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Santen Pharmaceutical Co., Ltd. researches and develops, produces, and markets pharmaceuticals and medical devices in Japan and internationally. It offers prescription pharmaceutical products for glaucoma and ocular hypertension, dry eyes, allergic conjunctivitis, severe keratitis with dry eyes, vernal keratoconjunctivitis, uveitis, wet age-related macular degeneration, and myopia; and over-the-counter pharmaceutical products. The company was formerly known as Santendo Pharmaceutical Co., Ltd. and changed its name to Santen Pharmaceutical Co., Ltd. in 1958. Santen Pharmaceutical Co., Ltd. was founded in 1890 and is headquartered in Osaka, Japan.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Health Medical Specialties Hypertension Coma Glaucoma Macular Degeneration Conjunctivitis Prescription Pharmaceutical Products Counter Pharmaceutical Products Over The Counter Pharmaceutical Products Wet Age Related Macular Degeneration Allergic Conjunctivitis Markets Pharmaceuticals Ocular Hypertension Pharmaceuticals And Medical Devices Uveitis Vernal Keratoconjunctivitis Myopia Santen Pharmaceutical Severe Keratitis Vernal Keratoconjunctivitis

Is SNPHY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 20.93
52 Week Low 12.63
Average Volume 59,534
200-Day Moving Average 17.1522
50-Day Moving Average 14.6473
20-Day Moving Average 13.8645
10-Day Moving Average 13.8650
Average True Range 0.3975
ADX 17.84
+DI 21.7534
-DI 25.6874
Chandelier Exit (Long, 3 ATRs ) 13.3375
Chandelier Exit (Short, 3 ATRs ) 13.8225
Upper Bollinger Band 14.4616
Lower Bollinger Band 13.2674
Percent B (%b) 0.32
BandWidth 8.6134
MACD Line -0.1705
MACD Signal Line -0.2090
MACD Histogram 0.0385
Fundamentals Value
Market Cap 5.45 Billion
Num Shares 400 Million
EPS 0.77
Price-to-Earnings (P/E) Ratio 17.84
Price-to-Sales 2.79
Price-to-Book 2.13
PEG Ratio 0.00
Dividend 0.26
Dividend Yield 1.90%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.8900
Resistance 3 (R3) 13.8967 13.8233 13.8500
Resistance 2 (R2) 13.8233 13.7622 13.8200 13.8367
Resistance 1 (R1) 13.7367 13.7245 13.7800 13.7300 13.8233
Pivot Point 13.6633 13.6633 13.6850 13.6600 13.6633
Support 1 (S1) 13.5767 13.6022 13.6200 13.5700 13.4767
Support 2 (S2) 13.5033 13.5645 13.5000 13.4633
Support 3 (S3) 13.4167 13.5033 13.4500
Support 4 (S4) 13.4100